Crossmark

A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients

Crossref DOI link: https://doi.org/10.1038/s41598-020-80052-3

Published Online: 2021-01-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prasoppokakorn, Thaninee

Vanichanan, Jakapat

Chaiteerakij, Roongruedee

Jutivorakool, Kamonwan

Udomkarnjananun, Suwasin

Pongpirul, Krit

Taesombat, Wipusit

Wattanatorn, Salin

Avihingsanon, Yingyos

Tungsanga, Kriang

Eiam-Ong, Somchai

Praditpornsilpa, Kearkiat

Townamchai, Natavudh
Funding

Funding for this research was provided by:

Chulalongkorn University (RA61/068)
License Information

Text and Data Mining valid from 2021-01-08

Version of Record valid from 2021-01-08
More Information

Article History

Received: 31 August 2020

Accepted: 16 December 2020

First Online: 8 January 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below